Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Rabe

Showing results (241-250 of 646) with videos related to

Pageof 65
Sort By:
American Journal of Respiratory and Critical Care Medicine|September 11, 2001
Factors associated with persistent airflow limitation in severe asthmaA ten Brinke, A H Zwinderman, P J Sterk, et al.
American Journal of Respiratory and Critical Care Medicine|October 3, 2013
An official American Thoracic Society/European Respiratory Society policy statement: disparities in respiratory healthDean E Schraufnagel, Francesco Blasi, Monica Kraft, et al.
The European Respiratory Journal|December 8, 2018
Economic burden of bronchiectasis in GermanyRoland Diel, James D Chalmers, Klaus F Rabe, et al.
The European Respiratory Journal|January 2, 2009
Safety of long-acting beta-agonists: urgent need to clear the air remainsR Beasley, F D Martinez, A Hackshaw, et al.
American Journal of Respiratory and Critical Care Medicine|June 25, 2004
"Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroidsAnneke ten Brinke, Aeilko H Zwinderman, Peter J Sterk, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 22, 2019
Rating sputum cell quality in clinical trials for asthma and COPD treatmentFrauke Pedersen, Ulrich M Zissler, Henrik Watz, et al.
Chest|February 8, 2018
Microbiologic Outcome of Interventions Against Mycobacterium avium Complex Pulmonary Disease: A Systematic ReviewRoland Diel, Albert Nienhaus, Felix C Ringshausen, et al.
Lancet (London, England)|October 7, 2008
A vision statement on guideline development for respiratory disease: the example of COPDHolger J Schünemann, Mark Woodhead, Antonio Anzueto, et al.
The European Respiratory Journal|April 28, 2017
Burden of non-tuberculous mycobacterial pulmonary disease in GermanyRoland Diel, Josephine Jacob, Niklas Lampenius, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 31, 2001
The effect of the vasoactive intestinal polypeptide agonist Ro 25-1553 on induced tone in isolated human airways and pulmonary arteryD T Schmidt, E Rühlmann, B Waldeck, et al.
Pageof 65

Showing results (241-250 of 646) with videos related to

Sort By:
Pageof 65
American Journal of Respiratory and Critical Care Medicine|September 11, 2001
Factors associated with persistent airflow limitation in severe asthmaA ten Brinke, A H Zwinderman, P J Sterk, et al.
American Journal of Respiratory and Critical Care Medicine|October 3, 2013
An official American Thoracic Society/European Respiratory Society policy statement: disparities in respiratory healthDean E Schraufnagel, Francesco Blasi, Monica Kraft, et al.
The European Respiratory Journal|December 8, 2018
Economic burden of bronchiectasis in GermanyRoland Diel, James D Chalmers, Klaus F Rabe, et al.
The European Respiratory Journal|January 2, 2009
Safety of long-acting beta-agonists: urgent need to clear the air remainsR Beasley, F D Martinez, A Hackshaw, et al.
American Journal of Respiratory and Critical Care Medicine|June 25, 2004
"Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroidsAnneke ten Brinke, Aeilko H Zwinderman, Peter J Sterk, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 22, 2019
Rating sputum cell quality in clinical trials for asthma and COPD treatmentFrauke Pedersen, Ulrich M Zissler, Henrik Watz, et al.
Chest|February 8, 2018
Microbiologic Outcome of Interventions Against Mycobacterium avium Complex Pulmonary Disease: A Systematic ReviewRoland Diel, Albert Nienhaus, Felix C Ringshausen, et al.
Lancet (London, England)|October 7, 2008
A vision statement on guideline development for respiratory disease: the example of COPDHolger J Schünemann, Mark Woodhead, Antonio Anzueto, et al.
The European Respiratory Journal|April 28, 2017
Burden of non-tuberculous mycobacterial pulmonary disease in GermanyRoland Diel, Josephine Jacob, Niklas Lampenius, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 31, 2001
The effect of the vasoactive intestinal polypeptide agonist Ro 25-1553 on induced tone in isolated human airways and pulmonary arteryD T Schmidt, E Rühlmann, B Waldeck, et al.
Pageof 65